Amidst a resurgence of COVID-19 cases across the United States, pharmaceutical company Gilead Sciences, Inc. has announced a voluntary recall of its antiviral drug Veklury, commonly known as ...
Shares of Gilead Sciences Inc. GILD inched 0.06% higher to $83.99 Monday, on what proved to be an all-around great trading ...
Investor's Business Daily on MSN4h
AstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer DrugAstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...
The Healthy on MSN8h
A COVID Medication Has Been Recalled NationwideThe manufacturer says the drug is indicated for the treatment of Covid-19 in adults and children, but an unexpected presence ...
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...
With rapid innovations in biotechnology, companies are developing groundbreaking therapies and diagnostic tools that address ...
IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...
There are now multiple forms of injectable PrEP medications. Lenacapavir, which is Gilead's injectable drug, differs from ...
In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback